Surgery News and Research

RSS

Mayo Clinic study finds that chromosomal rearrangements can help trace lineage of lung cancer

A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.

12 Nov 2014

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient’s specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world’s first patient-specific spinal osteosynthesis rod.

12 Nov 2014

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.

11 Nov 2014

UC San Diego Health System receives Leapfrog's highest grade for patient safety

Updating its unique Hospital Safety Score, which assigns A, B, C, D and F grades to hospitals nationwide based on their ability to prevent errors, injuries and infections, UC San Diego Health System has again been awarded separate A ratings for its hospitals in Hillcrest and La Jolla by The Leapfrog Group, an independent industry watchdog.

11 Nov 2014

Peter Munk Cardiac Centre surgeons successfully implant novel heart device

A surgical team at the Peter Munk Cardiac Centre led by internationally-acclaimed cardiovascular surgeon, Dr. Vivek Rao, has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced heart failure.

11 Nov 2014

New model explains how immune cells recognize, destroy bacteria

The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. Among the system's warriors are white blood cells including the specialized macrophages, which maintain constant surveillance for foreign intruders or pathogens, functioning as the body's first line of defense, poised to attack at barrier sites including the skin, lungs and intestines.

11 Nov 2014

Inovio Pharmaceuticals reports Q3 2014 financial results, provides corporate update

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2014.

10 Nov 2014

JPRAS Open: New open access journal from Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new, online-only open access journal, JPRAS Open .

10 Nov 2014

Effective treatment for phantom limb pain continues to be elusive

Army doctors in the First World War were helpless to stop soldiers who lost limbs from suffering in pain, according to researchers.

10 Nov 2014

Worst effects of reperfusion injury after heart attack may be prevented with iodide

Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.

9 Nov 2014

Stradis Healthcare signs definitive agreement to acquire Medikmark

Stradis Healthcare is pleased to announce that it has entered into a definitive acquisition agreement with Medikmark, a leading provider of healthcare kits based in Waukegan, IL, under which Stradis will acquire all shares of Medikmark.

7 Nov 2014

Should we be screening for colorectal cancer earlier?

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and women. Last year it was estimated that there had been around 143,000 new cases of CRC and 51,000 deaths due to CRC in the United States. The introduction of bowel screening for the over 50s has seen annual decreases in the overall incidence of CRC since 1998, giving cause for optimism.

7 Nov 2014

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Laparoscopic gastric bypass surgery in patients with type 2 diabetes, once considered a high-risk procedure, carries a complication and mortality rate comparable to some of the safest and most commonly performed surgeries in America, including gallbladder surgery, appendectomy, and total knee replacement, according to new research from the Cleveland Clinic Bariatric and Metabolic Institute.

7 Nov 2014

Greenwich Hospital partners with ONSF to conduct research on surgical site infections

Research on surgical site infections conducted at Greenwich Hospital in alliance with the ONS Foundation for Clinical Research and Education examined why a certain bacteria is so common in post-surgical shoulder infections and are helping to develop tactics to control it.

7 Nov 2014

Osteoporosis drugs may also benefit patients with tumours outside the skeleton

Australian researchers have shown why calcium-binding drugs commonly used to treat people with osteoporosis, or with late-stage cancers that have spread to bone, may also benefit patients with tumours outside the skeleton, including breast cancer.

6 Nov 2014

Scientists awarded grant to investigate new drug-based treatment for NF2

Scientists from Plymouth University Peninsula Schools of Medicine and Dentistry have been awarded a grant from young person's cancer charity The Laura Crane Youth Cancer Trust to investigate a new drug-based treatment for a multi-tumour brain and nervous system cancer which affects teenagers and young adults.

6 Nov 2014

Study sheds light on DCIS recurrence

Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist treatment and come back, as well as identifying a potential new target to improve the effectiveness of radiotherapy.

6 Nov 2014

UCSD engineers propose new single-ventricle heart surgery for children

Engineers at the University of California, San Diego, are proposing a new surgical intervention for children born with a single ventricle in their heart--instead of the usual two. The new approach would potentially reduce the number of surgeries the patients have to undergo in the first six months of life from two to just one. If successful, it would also create a more stable circuit for blood to flow from the heart to the lungs and the rest of the body within the first days and months of life.

6 Nov 2014

Weight-loss surgery minimizes use of medicines in people with obesity

Patients with obesity take significantly fewer medications after weight-loss surgery than their non-surgical counterparts, and end up spending 22.4 percent less on drugs for diabetes and heart disease after four years, according to new research.

6 Nov 2014

Dual intragastric balloon procedure shows promise for people with obesity

After six months, people with intragastric balloons in their stomachs lost more than twice their excess weight, compared to people who tried to lose weight under a medically supervised diet and exercise program alone, according to new research from a randomized clinical trial presented here at ObesityWeek 2014, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity.

6 Nov 2014